R Guimbaud

发表

A phase I clinical and pharmacokinetic study of capecitabine (Xeloda®) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours

J. Pierga, V. Diéras, R. Guimbaud, 2005, British Journal of Cancer.

A ‘DNA replication’ signature of progression and negative outcome in colorectal cancer

D. Trouche, P. Gourraud, M. Méchali, 2010, Oncogene.